These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33745437)

  • 1. Modifiable Risk Factors Associated with Alzheimer's Disease with Special Reference to Sleep Disturbance.
    Chauhan PS; Mishra M; Koul B; Sharma M; Yadav D
    CNS Neurol Disord Drug Targets; 2021; 20(7):594-601. PubMed ID: 33745437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer's Disease.
    Minakawa EN; Wada K; Nagai Y
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.
    Bubu OM; Andrade AG; Umasabor-Bubu OQ; Hogan MM; Turner AD; de Leon MJ; Ogedegbe G; Ayappa I; Jean-Louis G G; Jackson ML; Varga AW; Osorio RS
    Sleep Med Rev; 2020 Apr; 50():101250. PubMed ID: 31881487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
    Yang Y; Li M; Leng B; Yao R; Xue S; Tan M; Sun H; Zhang J
    J Alzheimers Dis; 2023; 95(4):1685-1696. PubMed ID: 37718794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
    Cavuoto MG; Robinson SR; O'Donoghue FJ; Barnes M; Howard ME; Tolson J; Stevens B; Schembri R; Rosenzweig I; Rowe CC; Jackson ML
    J Alzheimers Dis; 2023; 96(1):149-159. PubMed ID: 37742634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in understanding of sleep disorders and disturbances for dementia risk and prevention.
    Lam A; Kong S; Naismith SL
    Curr Opin Psychiatry; 2024 Mar; 37(2):94-100. PubMed ID: 38226546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.
    Liguori C; Mercuri NB; Izzi F; Romigi A; Cordella A; Sancesario G; Placidi F
    Sleep; 2017 May; 40(5):. PubMed ID: 28329084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
    Ning S; Jorfi M
    J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of sleep disturbance and inflammation for Alzheimer's disease dementia.
    Irwin MR; Vitiello MV
    Lancet Neurol; 2019 Mar; 18(3):296-306. PubMed ID: 30661858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly.
    Daulatzai MA
    J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years.
    Winer JR; Mander BA; Kumar S; Reed M; Baker SL; Jagust WJ; Walker MP
    Curr Biol; 2020 Nov; 30(21):4291-4298.e3. PubMed ID: 32888482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.
    Osorio RS; Ayappa I; Mantua J; Gumb T; Varga A; Mooney AM; Burschtin OE; Taxin Z; During E; Spector N; Biagioni M; Pirraglia E; Lau H; Zetterberg H; Blennow K; Lu SE; Mosconi L; Glodzik L; Rapoport DM; de Leon MJ
    Neurobiol Aging; 2014 Jun; 35(6):1318-24. PubMed ID: 24439479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.
    Vanderheyden WM; Lim MM; Musiek ES; Gerstner JR
    J Neurosci; 2018 Mar; 38(12):2901-2910. PubMed ID: 29563238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep deficits in mild cognitive impairment are related to increased levels of plasma amyloid-β and cortical thinning.
    Sanchez-Espinosa MP; Atienza M; Cantero JL
    Neuroimage; 2014 Sep; 98():395-404. PubMed ID: 24845621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Gao F; Liu T; Tuo M; Chi S
    Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.
    Spinedi E; Cardinali DP
    Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course.
    Liguori C; Placidi F; Izzi F; Spanetta M; Mercuri NB; Di Pucchio A
    Alzheimers Res Ther; 2020 Jan; 12(1):5. PubMed ID: 31901236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It's complicated: The relationship between sleep and Alzheimer's disease in humans.
    Lucey BP
    Neurobiol Dis; 2020 Oct; 144():105031. PubMed ID: 32738506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-Related Changes Prior to Cognitive Dysfunction.
    Pérez-Carbonell L; Iranzo A
    Curr Neurol Neurosci Rep; 2023 Apr; 23(4):177-183. PubMed ID: 36881255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.